Asthma is a common chronic disease linking the airway in the lungs that affects the people of all age groups. The airways or bronchial tubes, allow air to come in and out of the lungs. The airway of asthmatic patients is generally inflamed and becomes swollen over time. This makes it difficult for air to move in and out of the lungs, causing symptoms such as coughing, wheezing, shortness of breath and/ or chest tightness.
The prevalence of asthma is expected to increase significantly in the coming years. The market for asthma drugs is driven by various factors including increasing global spending on medicines, increasing tobacco and cigarette consumption, rising prevalence of non-communicable diseases, more use of biologics, and increasing healthcare expenditure worldwide. The major upcoming trends in the asthma market include introduction of new severe asthma and Chronic Obstructive Pulmonary Disease (COPD) drugs, and introduction of new mechanisms that will help drive the market. However, there are certain challenges hindering the growth of the market. Such challenges include increased pricing pressures, patent expiries and introduction of generic drugs in the market.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=363110
The market for asthma and COPD drugs represents an area of potential opportunity in both developed and developing countries. Due to effectiveness and advancements in technology, a large number of companies are focusing to develop innovative asthma and COPD drugs and treatments. Further, the companies are combining businesses and spending comprehensively on research and development to develop effective treatment methods for asthma.
The present report provides a comprehensive analysis of the global asthma & COPD market with focus on regions like the U.S. and European Union. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules. The leading players operating in the industry include AstraZeneca, Merck and Co., Roche, Sanofi and Novartis which are also profiled in this report.
Table of Content
1. Overview1.1 Definition of Asthma
1.2 Types of Asthma
1.3 Triggers of Asthma
1.4 Treatment Options for Asthma
1.5 Chronic Obstructive Pulmonary Disease (COPD)
1.5.1 Difference between Asthma and COPD
1.5.2 Treatment Options for COPD
2. Market Analysis
2.1 Global Respiratory Market
2.1.1 Global Respiratory Therapeutics Market
2.1.2 Global Inhalation Drug Delivery Technologies Market
2.2 Global Asthma/COPD Market
2.2.1 Global Asthma/COPD Therapeutics Market
2.3 Global Severe Asthma Market
3. Regional Markets
3.1. The U.S.
3.2 European Union
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Global Spending on Medicines
4.1.2 Cigarette and Tobacco Consumption
4.1.3 Rising Prevalence of Non Communicable Diseases
4.1.4 Increasing Use of Biologic Drugs
4.1.5 Escalating Global GDP
4.1.6 Global Healthcare Expenditure
4.2 Key Trends and Developments
4.2.1 Launch of New Severe Asthma Drugs
4.2.2 Introduction of New COPD Drugs
4.3.1 Increased Pricing Pressure
4.3.2 Patent Expiries and Generic Drugs
5. Competitive Landscape
5.1 Global Respiratory Market
5.2 Global Severe Asthma Market
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=363110
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
Mr. Nachiket Ghumare,
USA-Canada Toll Free: 866-997-4948
Follow us on LinkedIn @ http://bit.ly/1TBmnVG